295 related articles for article (PubMed ID: 15714592)
1. Elevated nuclear maspin expression is associated with microsatellite instability and high tumour grade in colorectal cancer.
Bettstetter M; Woenckhaus M; Wild PJ; Rümmele P; Blaszyk H; Hartmann A; Hofstädter F; Dietmaier W
J Pathol; 2005 Apr; 205(5):606-14. PubMed ID: 15714592
[TBL] [Abstract][Full Text] [Related]
2. Angiogenic factor VEGF is decreased in human colorectal neoplasms showing DNA microsatellite instability.
Wynter CV; Simms LA; Buttenshaw RL; Biden KG; Young J; Leggett BA; Conrad RJ; Schoch EM; Jass JR; Praga Pillay S
J Pathol; 1999 Nov; 189(3):319-25. PubMed ID: 10547592
[TBL] [Abstract][Full Text] [Related]
3. Tumour-infiltrating lymphocytes in colorectal cancer with microsatellite instability are activated and cytotoxic.
Phillips SM; Banerjea A; Feakins R; Li SR; Bustin SA; Dorudi S
Br J Surg; 2004 Apr; 91(4):469-75. PubMed ID: 15048750
[TBL] [Abstract][Full Text] [Related]
4. Fas ligand and tumour counter-attack in colorectal cancer stratified according to microsatellite instability status.
Michael-Robinson JM; Pandeya N; Cummings MC; Walsh MD; Young JP; Leggett BA; Purdie DM; Jass JR; Radford-Smith GL
J Pathol; 2003 Sep; 201(1):46-54. PubMed ID: 12950016
[TBL] [Abstract][Full Text] [Related]
5. Paradoxical expression of maspin in gastric carcinomas: correlation with carcinogenesis and progression.
Yu M; Zheng H; Tsuneyama K; Takahashi H; Nomoto K; Xu H; Takano Y
Hum Pathol; 2007 Aug; 38(8):1248-55. PubMed ID: 17490717
[TBL] [Abstract][Full Text] [Related]
6. Methylation of the hMLH1 and hMSH2 promoter in early-onset sporadic colorectal carcinomas with microsatellite instability.
Kim HC; Kim CN; Yu CS; Roh SA; Kim JC
Int J Colorectal Dis; 2003 May; 18(3):196-202. PubMed ID: 12673483
[TBL] [Abstract][Full Text] [Related]
7. Silencing of the maspin gene by promoter hypermethylation in thyroid cancer.
Boltze C; Schneider-Stock R; Quednow C; Hinze R; Mawrin C; Hribaschek A; Roessner A; Hoang-Vu C
Int J Mol Med; 2003 Oct; 12(4):479-84. PubMed ID: 12964023
[TBL] [Abstract][Full Text] [Related]
8. Colorectal cancers with microsatellite instability display mRNA expression signatures characteristic of increased immunogenicity.
Banerjea A; Ahmed S; Hands RE; Huang F; Han X; Shaw PM; Feakins R; Bustin SA; Dorudi S
Mol Cancer; 2004 Aug; 3():21. PubMed ID: 15298707
[TBL] [Abstract][Full Text] [Related]
9. Alterations in the tissue inhibitor of metalloproteinase-3 (TIMP-3) are found frequently in human colorectal tumours displaying either microsatellite stability (MSS) or instability (MSI).
Brueckl WM; Grombach J; Wein A; Ruckert S; Porzner M; Dietmaier W; Rümmele P; Croner RS; Boxberger F; Kirchner T; Hohenberger W; Hahn EG; Jung A
Cancer Lett; 2005 Jun; 223(1):137-42. PubMed ID: 15890246
[TBL] [Abstract][Full Text] [Related]
10. The putative tumor suppressor AIM2 is frequently affected by different genetic alterations in microsatellite unstable colon cancers.
Woerner SM; Kloor M; Schwitalle Y; Youmans H; Doeberitz Mv; Gebert J; Dihlmann S
Genes Chromosomes Cancer; 2007 Dec; 46(12):1080-9. PubMed ID: 17726700
[TBL] [Abstract][Full Text] [Related]
11. Different gene expression profiles between microsatellite instability-high and microsatellite stable colorectal carcinomas.
Kim H; Nam SW; Rhee H; Shan Li L; Ju Kang H; Hye Koh K; Kyu Kim N; Song J; Tak-Bun Liu E; Kim H
Oncogene; 2004 Aug; 23(37):6218-25. PubMed ID: 15208663
[TBL] [Abstract][Full Text] [Related]
12. High prevalence of Foxp3 and IL17 in MMR-proficient colorectal carcinomas.
Le Gouvello S; Bastuji-Garin S; Aloulou N; Mansour H; Chaumette MT; Berrehar F; Seikour A; Charachon A; Karoui M; Leroy K; Farcet JP; Sobhani I
Gut; 2008 Jun; 57(6):772-9. PubMed ID: 17965063
[TBL] [Abstract][Full Text] [Related]
13. Nuclear maspin expression correlates with the CpG island methylator phenotype and tumor aggressiveness in colorectal cancer.
Kim JH; Cho NY; Bae JM; Kim KJ; Rhee YY; Lee HS; Kang GH
Int J Clin Exp Pathol; 2015; 8(2):1920-8. PubMed ID: 25973084
[TBL] [Abstract][Full Text] [Related]
14. N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer.
Melotte V; Lentjes MH; van den Bosch SM; Hellebrekers DM; de Hoon JP; Wouters KA; Daenen KL; Partouns-Hendriks IE; Stessels F; Louwagie J; Smits KM; Weijenberg MP; Sanduleanu S; Khalid-de Bakker CA; Oort FA; Meijer GA; Jonkers DM; Herman JG; de Bruïne AP; van Engeland M
J Natl Cancer Inst; 2009 Jul; 101(13):916-27. PubMed ID: 19535783
[TBL] [Abstract][Full Text] [Related]
15. Transcriptional silencing of hedgehog-interacting protein by CpG hypermethylation and chromatic structure in human gastrointestinal cancer.
Taniguchi H; Yamamoto H; Akutsu N; Nosho K; Adachi Y; Imai K; Shinomura Y
J Pathol; 2007 Oct; 213(2):131-9. PubMed ID: 17724792
[TBL] [Abstract][Full Text] [Related]
16. The bone morphogenetic protein pathway is inactivated in the majority of sporadic colorectal cancers.
Kodach LL; Wiercinska E; de Miranda NF; Bleuming SA; Musler AR; Peppelenbosch MP; Dekker E; van den Brink GR; van Noesel CJ; Morreau H; Hommes DW; Ten Dijke P; Offerhaus GJ; Hardwick JC
Gastroenterology; 2008 May; 134(5):1332-41. PubMed ID: 18471510
[TBL] [Abstract][Full Text] [Related]
17. Maspin expression is transactivated by p63 and is critical for the modulation of lung cancer progression.
Kim S; Han J; Kim J; Park C
Cancer Res; 2004 Oct; 64(19):6900-5. PubMed ID: 15466179
[TBL] [Abstract][Full Text] [Related]
18. Maspin expression in invasive breast cancer: association with other prognostic factors.
Mohsin SK; Zhang M; Clark GM; Craig Allred D
J Pathol; 2003 Apr; 199(4):432-5. PubMed ID: 12635133
[TBL] [Abstract][Full Text] [Related]
19. Promoter methylation of TGFbeta receptor I and mutation of TGFbeta receptor II are frequent events in MSI sporadic gastric carcinomas.
Pinto M; Oliveira C; Cirnes L; Carlos Machado J; Ramires M; Nogueira A; Carneiro F; Seruca R
J Pathol; 2003 May; 200(1):32-8. PubMed ID: 12692838
[TBL] [Abstract][Full Text] [Related]
20. Close localization of DAP-kinase positive tumour-associated macrophages and apoptotic colorectal cancer cells.
Schneider-Stock R; Kuester D; Ullrich O; Mittag F; Habold C; Boltze C; Peters B; Krueger S; Hintze C; Meyer F; Hartig R; Roessner A
J Pathol; 2006 May; 209(1):95-105. PubMed ID: 16575786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
